NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

OptiNose Inc (F: 0OP)

 
0OP Technical Analysis
5
As on 20th Nov 2024 0OP STOCK Price closed @ 0.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.17 & Strong Sell for SHORT-TERM with Stoploss of 1.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

0OPSTOCK Price

Open 0.31 Change Price %
High 0.31 1 Day 0.00 0.00
Low 0.28 1 Week -0.42 -60.00
Close 0.28 1 Month -0.34 -54.84
Volume N/A 1 Year -0.78 -73.58
52 Week High 1.69 | 52 Week Low 0.01
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
HGF2 7.40 1380.00%
 
F Germany Top Losers Stocks
CMID 0.00 -100.00%
CMID 0.00 -100.00%
CMID 0.00 -100.00%
3MW 0.00 -100.00%
3MW 0.00 -100.00%
BRTN 0.00 -100.00%
BRTN 0.00 -100.00%
2TU 0.00 -100.00%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
 
 
0OP
Daily Charts
0OP
Intraday Charts
Whats New @
Bazaartrend
0OP
Free Analysis
 
0OP Important Levels Intraday
RESISTANCE0.34
RESISTANCE0.32
RESISTANCE0.31
RESISTANCE0.30
SUPPORT0.26
SUPPORT0.25
SUPPORT0.24
SUPPORT0.22
 
0OP Forecast November 2024
4th UP Forecast1.13
3rd UP Forecast0.86
2nd UP Forecast0.69
1st UP Forecast0.52
1st DOWN Forecast0.04
2nd DOWN Forecast-0.13
3rd DOWN Forecast-0.3
4th DOWN Forecast-0.57
 
0OP Weekly Forecast
4th UP Forecast0.47
3rd UP Forecast0.41
2nd UP Forecast0.37
1st UP Forecast0.33
1st DOWN Forecast0.23
2nd DOWN Forecast0.19
3rd DOWN Forecast0.15
4th DOWN Forecast0.09
 
0OP Forecast2024
4th UP Forecast3.69
3rd UP Forecast2.6
2nd UP Forecast1.92
1st UP Forecast1.24
1st DOWN Forecast-0.68
2nd DOWN Forecast-1.36
3rd DOWN Forecast-2.04
4th DOWN Forecast-3.13
 
 
0OP Other Details
Segment EQ
Market Capital 117279800.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
0OP Address
0OP
 
0OP Latest News
 
Your Comments and Response on OptiNose Inc
 
0OP Business Profile
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania. Address: 1020 Stony Hill Road, Yardley, PA, United States, 19067
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service